Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses N Joller, E Lozano, PR Burkett, B Patel, S Xiao, C Zhu, J Xia, TG Tan, ... Immunity 40 (4), 569-581, 2014 | 884 | 2014 |
The TIGIT/CD226 axis regulates human T cell function E Lozano, M Dominguez-Villar, V Kuchroo, DA Hafler The Journal of Immunology 188 (8), 3869-3875, 2012 | 483 | 2012 |
Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: A cross‐sectional screening of fifty‐four prospectively followed patients A García‐Martínez, J Hernández‐Rodríguez, P Arguis, P Paredes, ... Arthritis Care & Research 59 (3), 422-430, 2008 | 221 | 2008 |
TGF-β induces IL-9 production from human Th17 cells G Beriou, EM Bradshaw, E Lozano, CM Costantino, WD Hastings, ... The Journal of Immunology 185 (1), 46-54, 2010 | 218 | 2010 |
Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis G Espígol-Frigolé, M Corbera-Bellalta, E Planas-Rigol, E Lozano, ... Annals of the rheumatic diseases 72 (9), 1481-1487, 2013 | 119 | 2013 |
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis—a prospective longitudinal study S Visvanathan, MU Rahman, GS Hoffman, S Xu, A García-Martínez, ... Rheumatology 50 (11), 2061-2070, 2011 | 119 | 2011 |
Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell … M Corbera-Bellalta, E Planas-Rigol, E Lozano, N Terrades-García, ... Annals of the rheumatic diseases 75 (6), 1177-1186, 2016 | 118 | 2016 |
The CD226/CD155 interaction regulates the proinflammatory (Th1/Th17)/anti-inflammatory (Th2) balance in humans E Lozano, N Joller, Y Cao, VK Kuchroo, DA Hafler The Journal of Immunology 191 (7), 3673-3680, 2013 | 102 | 2013 |
Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin‐6) in the long‐term followup of patients with giant cell arteritis A García‐Martínez, J Hernández‐Rodríguez, G Espígol‐Frigolé, ... Arthritis care & research 62 (6), 835-841, 2010 | 100 | 2010 |
Imatinib mesylate inhibits in vitro and ex vivo biologic responses related to vascular occlusion in giant-cell arteritis E Lozano, M Segarra, A García-Martínez, J Hernández-Rodríguez, ... Annals of the rheumatic diseases, 2007 | 92 | 2007 |
Gelatinase expression and proteolytic activity in giant-cell arteritis M Segarra, A García-Martínez, M Sánchez, J Hernández-Rodríguez, ... Annals of the rheumatic diseases 66 (11), 1429-1435, 2007 | 90 | 2007 |
Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis E Planas-Rigol, N Terrades-Garcia, M Corbera-Bellalta, E Lozano, ... Annals of the rheumatic diseases 76 (9), 1624-1634, 2017 | 79 | 2017 |
Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells M Segarra, C Vilardell, K Matsumoto, J Esparza, E Lozano, ... The FASEB Journal 19 (13), 1875-1877, 2005 | 76 | 2005 |
Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis. Association between elevated endothelin plasma levels and the … E Lozano, M Segarra, M Corbera-Bellalta, A García-Martínez, ... Annals of the rheumatic diseases, 2009 | 69 | 2009 |
Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis M Corbera-Bellalta, A García-Martínez, E Lozano, E Planas-Rigol, ... Annals of the rheumatic diseases 73 (3), 616-623, 2014 | 67 | 2014 |
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression C Fernandez de Larrea, I Isola, A Pereira, MT Cibeira, L Magnano, ... Leukemia 32 (6), 1427-1434, 2018 | 63 | 2018 |
The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling T Díaz, V Rodríguez, E Lozano, MP Mena, M Calderón, L Rosiñol, ... haematologica 102 (10), 1776-1784, 2017 | 53 | 2017 |
The spectrum of vascular involvement in giant‐cell arteritis: clinical consequences of detrimental vascular remodelling at different sites MC Cid, S PRIETO‐GONZÁLEZ, P Arguis, G ESPÍGOL‐FRIGOLÉ, ... Apmis 117, 10-20, 2009 | 53 | 2009 |
Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents MT Cibeira, M Rozman, M Segarra, E Lozano, L Rosiñol, MC Cid, ... Cytokine 41 (3), 244-253, 2008 | 49 | 2008 |
Influence of Mitochondrial Genetics on the Mitochondrial Toxicity of Linezolid in Blood Cells and Skin Nerve Fibers. CF Garrabou G, Soriano À, Pinós T, Casanova-Mollà J, Pacheu-Grau , Morén C ... Antimicrob Agents Chemother. 61 (9), e00542-17, 2017 | 45* | 2017 |